| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2000;18:513-518
© 2000 Elsevier Science NL
Department of Thoracic and Vascular Surgery and Heart–Lung Transplantation, Hopital Marie-Lannelongue (Paris-Sud University), 92350 Le Plessis Robinson, Paris, France
Received 28 December 1999; received in revised form 13 June 2000; accepted 12 July 2000.
Corresponding author. Tel.: +33-1-40942800; fax: +33-1-46303792
e-mail: alain.chapelier{at}ccml.com
Objective: Several reports emphasize the importance of en-bloc resection as the optimal surgical treatment of lung cancer with chest wall invasion. We investigated possible factors which could affect long-term survival following radical resection of these tumors. Methods: Between 1981 and 1998, 100 patients (90 male; ten female), with a median age of 60 years (36–84), underwent radical en-bloc resection of non-small cell lung cancer (NSCLC) with chest wall involvement. Patients with superior sulcus tumors invading the thoracic inlet were excluded from this series. There were 43 squamous and 57 non-squamous tumors. The median number of resected ribs was three (1–5). Lung resection included 73 lobectomies, two bilobectomies, 18 pneumonectomies and seven segmentectomies. Chest wall resection also extended to the sternum in one patient, the transverse process in one, the costotransverse foramen and hemivertebrae in two. All patients had a complete resection. Sixty-three patients received postoperative radiotherapy and 12 received chemotherapy. Histological data, including differentiation and depth of chest wall invasion, were carefully reviewed. The effect of various factors on survival were studied. Results: There were four in-hospital deaths. Lymph node involvement was negative on surgical specimens in 65 patients, and 28 patients had positive N1 nodes; the final histology revealed seven N2 diseases. Chest wall invasion was limited to the parietal pleura in 29 patients and included intercostal muscles, bones and extrathoracic muscles in 67, 24 and seven cases, respectively. The overall 2-year survival rate was 41%. The 5-year survival for patients with N0, N1 and N2 disease was 22, 9 and 0%, respectively. A local recurrence occurred in 13 patients, with four having a new resection and 45 patients developing systemic metastases. The nodal status (N0–1 vs. N2; P=0.026) and the number of resected ribs(<2 vs. >2; P=0.03) were survival predictors in univariate analysis. By multivariate analysis, the two independent factors affecting long-term survival were the histological differentiation (well vs. poorly differentiated; P=0.01) and the depth of chest wall invasion (parietal pleura vs. others; P=0.024). Conclusions: Histological differentiation and depth of chest wall involvement were the main factors affecting long-term survival in this series. The role of induction chemotherapy for tumors with poor prognosis should be investigated.
Key Words: Lung cancer • Chest wall involvement • En-bloc resection • Nodal status • Histological differentiation • Long-term survival
This article has been cited by other articles:
|
|
 |
|
  N. Sakakura, S. Mori, F. Ishiguro, T. Fukui, S. Hatooka, M. Shinoda, K. Yokoi, and T. Mitsudomi Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Ann. Thorac. Surg., October 1, 2008; 86(4): 1076 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Shen, B. F. Meyers, J. M. Larner, and D. R. Jones Special Treatment Issues in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 290S - 305S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Mineo, V. Ambrogi, E. Pompeo, and A. Baldi Immunohistochemistry-detected microscopic tumor spread affects outcome in en-bloc resection for T3-chest wall lung cancer Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1120 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Doddoli, B. D'Journo, F. Le Pimpec-Barthes, A. Dujon, C. Foucault, P. Thomas, and M. Riquet Lung Cancer Invading the Chest Wall: A Plea for En-Bloc Resection but the Need for New Treatment Strategies Ann. Thorac. Surg., December 1, 2005; 80(6): 2032 - 2040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bini, M. Grazia, F. Petrella, and R. Bazzocchi Pulmonary infiltration from retroperitoneal carcinoma requiring diaphragm, chest wall and lung resection after thoracoabdominal access Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 168 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.E. Martin-Ucar, R. Nicum, I. Oey, J.G. Edwards, and D.A. Waller En-bloc chest wall and lung resection for non-small cell lung cancer. Predictors of 60-day non-cancer related mortality Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 859 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Roviaro, F. Varoli, F. Grignani, C. Vergani, C. Pagano, M. Maciocco, and A. Romanelli Non-small Cell Lung Cancer With Chest Wall Invasion: Evolution of Surgical Treatment and Prognosis in the Last 3 Decades Chest, May 1, 2003; 123(5): 1341 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Mansour, V. H. Thourani, A. Losken, J. G. Reeves, J. I. Miller Jr, G. W. Carlson, and G. E. Jones Chest wall resections and reconstruction: a 25-year experience Ann. Thorac. Surg., June 1, 2002; 73(6): 1720 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riquet, L. Lang-Lazdunski, F. Le Pimpec-Barthes, A. Dujon, R. Souilamas, C. Danel, and D. Manac'h Characteristics and prognosis of resected T3 non-small cell lung cancer Ann. Thorac. Surg., January 1, 2002; 73(1): 253 - 258. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
